Commercial Printing

Document Security Systems, Inc. (NYSE: DMC) today announced that it has signed a licensing agreement with Buffalo, NY-based security printer Midwest Banknote Company. As part of the two-year agreement, Midwest Banknote has been granted a license to produce printed products such as certificates...

Document Security Systems, Inc. (NYSE: DMC) announced today that it received correspondences from NYSE Amex LLC dated March 15, 2011 confirming that its Additional Listing Applications have been approved by NYSE Amex and that DSS has regained full compliance with NYSE Amex continued listing...

M & F Worldwide Corp. (NYSE: MFW) today reported results for the fourth quarter and year ended December 31, 2010. Net revenues of $1,782.6 million, down $31.5 million, or 1.7%, as compared to 2009. Operating income of $313.6 million, up $47.4 million, or 17.8%, as compared to 2009. Net income...

Cenveo, Inc. (NYSE: CVO) today announced results for the three months ended January 1, 2011. For the three months ended January 1, 2011, net sales were $460.4 million, as compared to $456.8 million for the same period in the previous year. For the three months ended January 1, 2011, the Company...

Standard Register (NYSE: SR) today reported its fourth quarter and total year 2010 results. For the quarter, the Company reported revenue of $172.7 million and a net profit of $2.2 million, or $0.08 per share. The current year fourth quarter 13-week results compare to last year's 14-week revenue of...

InnerWorkings, Inc. (NASDAQ: INWK) today reported results for the fourth quarter and fiscal year ended December 31, 2010. Record revenue for the fourth quarter of $130.4 million, an increase of 20.9% compared to revenue of $107.9 million in the fourth quarter of 2009. Net income was $3.5 million...

InnerWorkings, Inc. (NASDAQ: INWK) today reported results for the fourth quarter and fiscal year ended December 31, 2010. Quarterly Highlights: Record revenue for the fourth quarter of $130.4 million, an increase of 20.9% compared to revenue of $107.9 million in the fourth quarter of 2009. Net...

Cloud Computing Deal with Verizon and Terremark Creates Top Trader for Investors POINT ROBERTS, Wash., January 28th 2011 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on late morning trading on the NASDAQ.com. The top gainers include: (NASDAQ: CHMP...

Novartis (NVS) reported earnings per share of $1.14 for the fourth quarter of 2010, much below the Zacks Consensus Estimate of $1.21 and the year-earlier earnings of $1.26 per share. The substantial drop from the base period was due to robust profits booked in 2009 from windfall sales of H1N1 flu...

Novartis (NVS) reported earnings per share of $1.14 for the fourth quarter of 2010, much below the Zacks Consensus Estimate of $1.21 and the year-earlier earnings of $1.26 per share. The substantial drop from the base period was due to robust profits booked in 2009 from windfall sales of H1N1 flu...

Novartis (NVS) recently announced that it has entered into a definitive agreement to acquire California based diagnostic laboratory, Genoptix Inc. (GXDX), for a cash consideration of $470 million. Genoptix is a specialist in providing personalized diagnostic services to community-based...

Novartis (NVS) recently announced that it has entered into a definitive agreement to acquire California based diagnostic laboratory, Genoptix Inc. (GXDX), for a cash consideration of $470 million. Genoptix is a specialist in providing personalized diagnostic services to community-based...

Deluxe Corporation (NYSE: DLX) reported fourth quarter revenue of $351.5 million, up 3% compared to the prior year, and adjusted diluted earnings per share of $0.78 compared to $0.70 in the prior year. Adjusted diluted EPS for both periods excludes restructuring costs related to our cost reduction...

Merck KGaA (MKGAF) recently said that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) upheld its negative recommendation related to the approval of cladribine for the treatment of relapsing-remitting multiple sclerosis (MS). In September last year,...

Merck KGaA (MKGAF) recently said that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) upheld its negative recommendation related to the approval of cladribine for the treatment of relapsing-remitting multiple sclerosis (MS). In September last year,...